Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dimov (Stara Zagora, Bulgaria), T. Tacheva (Stara Zagora, Bulgaria), Y. Zhelyazkova (Stara Zagora, Bulgaria), N. O'Donoghue (Stara Zagora, Bulgaria), D. Vlaykova (Stara Zagora, Bulgaria), T. Vlaykova (Stara Zagora, Bulgaria). Visfatin as a possible serum biomarker in COPD. 5408

Member's Comments

No comment yet.

Related content which might interest you: The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Investigation of possible role of serum fibulin as biomarker of COPD. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Cigarette smoking acutely decreases the serum levels of the COPD biomarker sRAGE Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics Year: 2018 Serum Club cell16 levels as a biomarker in tobacco-smoke COPD and biomass-smoke COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Circulating total leptin as a diagnostic and prognostic biomarker in sepsis Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Serum CC16 is a potential predictor for IPF diagnosis and prognosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Serum periostin and eotaxin-2 as promising biomarkers in asthmatic smokers. Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 The role of serum IL6 in stable COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Is serum leptin level a predictor for asthma? Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005